focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Update, Equity Issue & Total Voting Rights

15 May 2023 07:00

RNS Number : 3398Z
Barkby Group PLC
15 May 2023
 

Barkby Group PLC

 

("Barkby", the "Group" or the "Company")

 

 

Board Update, Issue of Equity and Total Voting Rights

 

 

Barkby, (AIM:BARK) announces that Jeremy Sparrow has stepped down from the Board and as a Non-Executive Director of the Group with immediate effect. A new Non-Executive Director appointment is currently under consideration.

 

Charles Dickson, Chairman of Barkby, said:

"The Board thanks Jeremy for his significant contribution to the Group over the last seven years and wishes him well in his future endeavours.

 

"Jeremy's guidance as we refocus the Company's activities on real estate opportunities has been invaluable. Our search for a new Non-Executive Director is underway and will ensure the Board retains the right balance of skills and experience to support the successful implementation of our strategy."

 

Issue of Equity

Barkby has today issued and allotted, in aggregate, 416,666 new Ordinary Shares of £0.00860675675675676 each in the capital of the Company, ("Ordinary Shares") to Douglas Alexander Benzie, a Director of the Company, in relation to an agreed equity grant upon completion of three years' service.

 

Application has been made to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on AIM, ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 am on 18 May 2023. The new Ordinary Shares will rank pari passu with the Company's existing shares.

 

Total Voting Rights

Following Admission the Company's issued share capital consists of 143,677,804 Ordinary Shares, each with voting rights. The Company does not hold any shares in treasury, therefore the total number of voting rights in the Company is 143,677,804, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Douglas Alexander Benzie

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Barkby Group plc

b)

LEI:

213800X57YXZVILB9E84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of £0.00860675675675676

GB00BL6TZZ70

b)

Nature of the transaction:

Issue of Ordinary Shares

c)

Price(s) and volume(s):

Price(s) pence

Volume(s)

£0.0086067p

416,666

d)

Aggregated information:

Aggregated volume:

Price:

Single transaction as in 4 (c) above

e)

Date of the transaction:

12 May 2023

f)

Place of the transaction:

Off market transaction

 

- Ends -

 

Enquiries:

 

Barkby Group PLC

Charles Dickson, Executive Chairman

Douglas Benzie, Chief Financial Officer

c/o Montfort Communications

 

 

finnCap Ltd (Nomad and Broker)

Carl Holmes/Simon Hicks (Corporate Finance)

Tim Redfern (ECM)

 

 

+44 (0)20 7220 0500

Montfort Communications

Olly Scott

Georgia Colkin

 

 

+44 (0)78 1234 5205

 

Notes to editors

Barkby Group PLC is focused on commercial property development and investment, alongside its pubs business. Barkby is in the process of disposing of its Investments comprising of Workshop Coffee and Cambridge Sleep Sciences.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFFIEIISLIV
12
Date   Source Headline
27th Oct 20219:05 amRNSSecond Price Monitoring Extn
27th Oct 20219:00 amRNSPrice Monitoring Extension
27th Oct 20217:00 amRNSTrading Statement and Property Acquisition
10th Aug 20217:00 amRNSTrading Statement
16th Jun 20217:00 amRNSNew lease for The Ebrington Arms
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
7th May 20211:48 pmRNSResult of AGM and change of name
30th Apr 20217:00 amRNSInterim Results
15th Apr 20217:00 amRNSCambridge Sleep Sciences signs new partners
9th Apr 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Apr 20217:00 amRNSVerso Biosense signs collaboration agreement
31st Mar 20216:29 pmRNSFinal Results
25th Mar 20217:00 amRNSVerso Biosense signs agreement with hospital
11th Mar 20217:00 amRNSCambridge Sleep Sciences partnership announcement
3rd Mar 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSExchange of Contracts at Malden, Essex
24th Dec 20207:00 amRNSExtension of Warrants
21st Dec 20207:00 amRNSExercise of Warrants and Total Voting Rights
6th Nov 20207:03 amRNSExtension of Reporting Deadline
30th Oct 20207:00 amRNSWorkshop Coffee becomes UK Distributor for MiiR
23rd Oct 20207:00 amRNSCambridge Sleep Sciences Ltd launches 'SleepHub™'
30th Sep 20207:00 amRNSCompany Update and Issue of Equity
17th Sep 20207:00 amRNSNew lease for The Harcourt Arms
10th Aug 20207:00 amRNSPractical Completion of Hastings
3rd Aug 20207:00 amRNSInvestment in VivoPlex Group
22nd Jul 20207:00 amRNSUpdate and CBILS loan
21st Apr 20207:00 amRNSAgreement with Cambridge Sound Technologies
20th Apr 20207:32 amRNSVivoPlex prepares for clinical feasibility study
24th Mar 20202:57 pmRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSConfirmation of Director Appointment
23rd Mar 20207:00 amRNSInterim Results
3rd Mar 20207:00 amRNSProposed acquisition
6th Feb 20207:00 amRNSAppointment of Senior Manager
3rd Feb 20207:00 amRNSAppointment of Chief Financial Officer
17th Jan 20207:00 amRNSExchange of Contracts at Huntingdon
7th Jan 20207:00 amRNSCompletion of Acquisition
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.